Co-immunization of plasmid DNA encoding IL-12 and IL-18 with bacillus Calmette-Guérin vaccine against progressive tuberculosis

Yonsei Medical Journal

Volumn 52, Issue 6, 2011, Pages 1008-1015

  Jeon, Bo Young ^a   Eoh, Hyungjin ^a   Ha, Sang Jun ^b   Bang, Hyeeun ^a   Kim, Seung Cheol ^a   Sung, Young Chul ^c   Cho, Sang Nae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

BCG; DNA vaccine; IL 12; IL 18; Tuberculosis

Indexed keywords

BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMONIA; SPLEEN CELL; TUBERCULOSIS;

ANIMALS; BCG VACCINE; FEMALE; IMMUNOENZYME TECHNIQUES; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; PLASMIDS; TUBERCULOSIS; VACCINES, DNA;

EID: 80055001750     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.6.1008     Document Type: Article

References (25)

1. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-6.
2. Snider DE Jr, Castro KG. The global threat of drug-resistant tuberculosis. N Engl J Med 1998;338:1689-90.
3. Hawgood BJ. Albert Calmette (1863-1933) and Camille Guérin (1872-1961): the C and G of BCG vaccine. J Med Biogr 2007;15:139-46.
4. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995;346:1339-45.
5. Weir RE, Gorak-Stolinska P, Floyd S, Lalor MK, Stenson S, Branson K, et al. Persistence of the immune response induced by BCG vaccination. BMC Infect Dis 2008;8:9.
6. Derrick SC, Yang AL, Morris SL. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 2004;23:780-8.
7. Olsen AW, Brandt L, Agger EM, van Pinxteren LA, Andersen P. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Scand J Immunol 2004;60:273-7.
8. Weinrich Olsen A, van Pinxteren LA, Meng Okkels L, Birk Rasmussen P, Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001;69:2773-8.
9. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Nasser Eddine A, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Invest 2005;115:2472-9.
10. Jeon BY, Derrick SC, Lim J, Kolibab K, Dheenadhayalan V, Yang AL, et al. Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice. Infect Immun 2008;76:5173-80.
11. Lee J, Hartman M, Kornfeld H. Macrophage apoptosis in tuberculosis. Yonsei Med J 2009;50:1-11.
12. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
13. Emoto M, Emoto Y. Intracellular bacterial infection and invariant NKT cells. Yonsei Med J 2009;50:12-21.
14. Jeong E, Lee JY. Intrinsic and extrinsic regulation n of innate immunereceptors. Yonsei Med J 2011;52:379-92.
15. Kinjo Y, Kawakami K, Uezu K, Yara S, Miyagi K, Koguchi Y, et al. Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J Immunol 2002;169:323-9.
16. Ha SJ, Park SH, Kim HJ, Kim SC, Kang HJ, Lee EG, et al. Enhanced immunogenicity and protective efficacy with the use of in terleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination. Infect Immun 2006;74:4954-9.
17. Luo Y, Yamada H, Chen X, Ryan AA, Evanoff DP, Triccas JA, et al. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity. Clin Exp Immunol 2004;137:24-34.
18. Martin E, Kamath AT, Briscoe H, Britton WJ. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guérin) in protecting gainst systemic Mycobacterim avium infection. Immunology 2003;109:308-14.
19. Palendira U, Kamath AT, Feng CG, Martin E, Chaplin PJ, Triccas JA, et al. Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosis. Infect Immun 2002;70:1949-56.
20. Triccas JA, Sun L, Palendira U, Britton WJ. Comparative affects of plasmid-encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis. Immunol Cell Biol 2002;80:346-50.
21. Jeon BY, Kim HJ, Kim SC, Jo EK, Park JK, Paik TH, et al. Protection of mice against Mycobacterium tuberculosis infection by immunization with aqueous fraction of Triton X-100-soluble cell wall proteins. Scand J Immunol 2008;67:18-23.
22. Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, Sung YC, et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther 2003;10:1592-9.
23. Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, Chen B, et al. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest 2007;117:2279-88.
24. Singha H, Mallick AI, Jana C, Isore DP, Goswami TK, Srivastava SK, et al. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus. Microbes Infect 2008;10:1089-96.
25. Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, et al. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. J Virol 2010;84:4073-82.